Skip to main content
. 2023 Aug 4;23(3):263. doi: 10.1007/s10142-023-01158-1

Fig. 7.

Fig. 7

Inherent molecular heterogeneity in high- and low-risk patients. A–C GSEA showed the discrepancies in the activities of KEGG-derived pathways between different risk subgroups in the training, test1, and test2 cohorts